Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Rami Khayat , Andrew Pederzoli , William T Abraham Added: 3 years ago
Heart failure is the only cardiovascular disease with increasing incidence and mortality.1 Approximately five million Americans have heart failure, with an annual incidence of 10 per 1,000 in individuals over 65 years of age, an already rising demographic segment of society. Heart failure is the most frequent Medicare diagnosis, with most of its cost related to hospitalizations.1,2 Identification… View more
Author(s): Sitaramesh Emani , William T Abraham Added: 3 years ago
Heart failure (HF) is a growing epidemiological challenge in the US and worldwide. In the US, it is estimated that at least 5 million people are affected by it, with more than a half-million new diagnosis being made each year.1 Despite major improvements in the treatment of HF, almost 30 % of patients treated for acute HF require readmission within 30 days.2,3 These sobering statistics underscore… View more
Author(s): Philip Adamson Added: 3 years ago
A growing appreciation of the prevalence of sleep breathing disorders, especially as comorbidities of disease syndromes such as chronic heart failure, has increased interest in screening, diagnosis, and treatment of obstructive and central sleep apnea. Sleep apnea diagnosis currently requires an overnight polysomnograhic evaluation in which the disease is defined as the number of times per hour… View more
Author(s): Douglas Bradley Added: 1 year ago
ESC 22 - In this short interview filmed onsite at ESC Congress 2022, Dr Douglas Bradley (University of Toronto, Toronto, CA) discusses the findings of the ADVENT-HF Trial (NCT01128816). ADVENT-HF was designed to determine if a respiratory device, Adaptive Servo Ventilation can reduce the risk of cardiovascular hospitalisations and death in patients with heart failure and sleep apnoea. 732… View more
Research Area(s) / Expertise:

Heart Failure

Job title: Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve… View more
Job title: Cardiologist and Associate Professor
Personal History Dr Dominik Linz is a clinician-scientist who has developed a national and international reputation in the field of cardiac arrhythmia research.2 He is a cardiologist and associate professor at Maastricht University Medical Center+ in the Netherlands. Academic History In 2007, Dr Linz earned his MD from Johannes Gutenberg University of Mainz, Germany. He then… View more
Job title: Interventional Cardiologist
Dr. Hakim Ben Amer MEDICAL EDUCATION AND ACADEMIC DEGREES - 1981-1987 Medical studies (Medical School Pitié-Salpétrière, University Paris VI). MD degree. - 1987 Certificate of clinical and therapeutic synthesis (Medical School Pitié-Salpétrière, University Paris VI). -1987 Residency in Paris Hospitals -1992 Completion of the cardiology specialty level (Diploma of specialized studies in… View more
Author(s): Tasneem Z Naqvi Added: 3 years ago
Congestive heart failure (CHF) is the number one hospital discharge diagnosis for older adults and the leading cause of hospital readmissions, reflecting poor quality of life for patients and increased healthcare resource use, and is the cause of 300,000 deaths annually.1 Cardiac resynchronization therapy (CRT) has become a new effective treatment modality in those with drug-resistant advanced… View more
Author(s): Pragnesh Parikh , KL Venkatachalam Added: 3 years ago
Atrial fibrillation (AF) is the most common pathologic clinical arrhythmia lasting more than 30 seconds, and its incidence and prevalence continue to increase. It has been estimated that 5.9 % of patients aged >65 years suffer from AF.1 In the Rotterdam study, 17.8 % of patients over 85 had AF.2 The lifetime risk for developing AF in both men and women above age 40 is one in four.3 This… View more
Author(s): Deepak Padmanabhan , Ameesh Isath , Bernard J Gersh Added: 3 years ago
Endovascular techniques for renal denervation (RDN) as a treatment for hypertension were initially highly encouraging with reductions in blood pressure (BP) in the range of 30 mmHg.1 However, these high expectations received a major setback following the unexpected results of the sham-controlled Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3) trial. This promising… View more